I’d Pay Very Close Attention to This if I Were a Marijuana Investor

Earlier this month, Aphria Inc. (TSX:APH) announced its plans to make a multi-million-dollar investment in a new state-of-the-art production facility outside its Leamington headquarters. Find out if this could mark a turning point for the rest of the cannabis industry.

| More on:

On June 6, Aphria Inc. (TSX:APH), Canada’s third-largest medical marijuana company, announced that it plans to invest $55 million to build a brand new, state-of-the-art extraction facility.

In announcing the move, the company spun it as a social governance initiative: “We’re expanding our horizons in Leamington so that when our youth go away to school they’ve got something to come home to.”

And while there may be some truth to the company’s statement that the move is intended as a grassroots initiative to help provide skilled employment for local youth living near the company’s Leamington headquarters, the multi-million-dollar investment is far more about exploiting the apparent opportunities in marijuana extraction than anything else.

The planned facility will be capable of processing over 200,000 kilograms of marijuana plant annually, with the first deliveries expected towards the end of the first quarter in 2019.

Through advanced extraction methods involving the use of butane, ethanol, and CO2, the company aims to produce “world-class cannabis concentrates” that can then be converted into a myriads of applications from powders, creams, patches, edibles, and even infused beverages.

While it hasn’t received a tonne of attention in the mainstream press to date, those Fools fortunate to be blessed with shrewd memories may recall that Constellation Brands, Inc. (NYSE:STZ), one of the world’s largest alcoholic beverage makers, specifically touted the potential it saw in infused beverages last fall when it announced it was making a $245 million investment in Canopy Growth Corp. (TSX:WEED)(NYSE:CGC).

As Aphria’s chief financial officer Carl Merton said in announcing the company’s latest investment, the investment in extraction facilities sets the company up for “the wave after [this one] that no one even knows about yet.”

The proof is in the pudding…

Maybe the latest news shouldn’t come as such a surprise to those who have been following the evolution of Canada’s cannabis markets closely over the past few years.

As the market for product has matured, more sales for Canada’s licensed medical producers (recreational marijuana is still not legally available for sale) are coming from the sale of derivative products like oils, edibles and creams — rather than simply sales of the traditional marijuana flower.

Not only do oils and other derivative or extract products tend to carry with them higher margins for producers like Aphria (a good thing), they also promote several health benefits with them as compared to smoking the traditional flower through a cigarette or pipe.

A look to the future

As the values of licensed marijuana producers have soared in recent years, it only becomes more difficult for investors uncover the true “value” that remains hidden in the market.

One avenue worth considering is, of course, the implications for companies like Aphria, Canopy Growth, Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) and others to tap into the many international markets that continue to open.

But many are already looking at that opportunity square on — meaning that the next leg of the marijuana rally may actually end up coming from an advanced understanding of which manufacturers are able to lead the industry through innovation, including Aphria’s latest initiative.

Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Phillips owns shares in Aphria Inc.

More on Investing

funds, money, nest egg

Retirees: 3 Canadian Stocks You Can Confidently Own for the Next 20 Years

Here's why retirees need to plan beyond 20 years in retirement. Fortis Inc. (TSX:FTS), Royal Bank of Canada (TSX:RY) stock…

Read more »

Question marks in a pile
Tech Stocks

Should You Invest in Absolute Software Stock Right Now?

Absolute Software (TSX:ABST) is a tech stock that is worth your attention, as it offers exposure to exciting security markets.

Read more »

Dividend Stocks

1 Oversold Dividend Stock I’d Buy in December 2022

Here’s one of the best Canadian dividend stocks to buy in December that I find undervalued.

Read more »


FOR TUESDAY – 3 TSX Stocks to Buy Today and Hold for the Next 3 Years

Given their growth prospects, these three TSX stocks could outperform over the next three years.

Read more »

Supermarket aisle with empty green shopping cart
Stocks for Beginners

Is Dollarama Stock a Buy at All-Time Highs?

Dollarama stock (TSX:DOL) remains at all-time highs while the rest of the market drops. Does this mean it's due to…

Read more »

Online shopping
Tech Stocks

Should You Buy Shopify Stock If the Rate Hike Cycle Slows?

Is SHOP stock a buy after its 72% drop this year?

Read more »

A bull outlined against a field

2 Canadian Stocks Set to Soar in a New Bull Market

Consider Sleep Country Canada Holdings (TSX:ZZZ) stock and another mid-cap bargain, as the bear market moves on.

Read more »

Gold bars
Metals and Mining Stocks

Better Buy: Newmont or Barrick Gold Stock?

If you think better days are ahead for gold miners, consider exploring gold stocks Newmont and Barrick Gold.

Read more »